SAR445088 (formerly BIVV020) ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
14	Chronic inflammatory demyelinating polyneuropathy	2

14. Chronic inflammatory demyelinating polyneuropathy

Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004006-54-DE (EUCTR)	23/06/2021	08/03/2021	Proof-of-concept study for BIVV020 in chronic inflammatory demyelinating polyneuropathy (CIDP)	Phase 2, multicenter, open-label, non-randomized,proof-of-concept study evaluating the efficacy, saf ...	Chronic inflammatory demyelinatingpolyneuropathy MedDRA version: 20.0;Level: LLT;Classification code ...	Product Code: SAR445088 (formerly BIVV020) Other descriptive name: BIVV020	Sanofi-Aventis Recherche & Développement	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 2	France;Poland;Netherlands;Germany;Italy
2	EUCTR2020-004006-54-PL (EUCTR)	29/04/2021	31/03/2021	Proof-of-concept study for BIVV020 in chronic inflammatory demyelinating polyneuropathy (CIDP)	Phase 2, multicenter, open-label, non-randomized,proof-of-concept study evaluating the efficacy, saf ...	Chronic inflammatory demyelinatingpolyneuropathy MedDRA version: 20.0;Level: LLT;Classification code ...	Product Code: SAR445088 (formerly BIVV020) Other descriptive name: BIVV020	Sanofi-Aventis Recherche & Développement	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 2	France;Poland;Germany;Netherlands;Italy

First Previous1Next Last